ENGERIX-B (GlaxoSmithKline Biologicals SA)


Welcome to the PulseAid listing for the ENGERIX-B drug offered from GlaxoSmithKline Biologicals SA. This pharmaceutical is classified as a VACCINE. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.

LABELER NAME / MANUFACTURER: GlaxoSmithKline Biologicals SA
NON-PROPRIETARY NAME: Hepatitis B Vaccine (Recombinant)
SUBSTANCE NAME: HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN
TYPE: VACCINE
PHARMA CLASS:
ROUTE: INTRAMUSCULAR
DOSAGE FORM: INJECTION, SUSPENSION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2007-04-25
END MARKETING DATE: 0000-00-00


ENGERIX-B VACCINE Details:

Item DescriptionENGERIX-B from GlaxoSmithKline Biologicals SA
LABELER NAME: GlaxoSmithKline Biologicals SA
DEA SCHEDULE:
ACTIVE STRENGTH: 10(ug/.5mL)
START MARKETING DATE: 2007-04-25
END MARKETING DATE: 0000-00-00
PRODUCT ID: 58160-820_bac87f9e-8514-477a-8c92-3a5ed504ddc5
PRODUCT NDC: 58160-820
APPLICATION NUMBER: BLA103239

Other HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Dispensing Solutions Inc.ENGERIX-B
GlaxoSmithKline Biologicals SAENGERIX-B